← Leaderboards
Sudhir Pai Kasturi
Emory University
$6,079,601
Attributed
$6,079,601
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2016–23$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,079,601 · 2
By mechanism
R01$5,035,248 · 1
K01$1,044,353 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Rama Rao Amara$90,840,294
- Jeremy M. Boss$41,716,661
- Arash Grakoui$19,890,946
- Rafi Ahmed$104,632,759
- Francois J Villinger$61,853,654
Others in their field
Top investigators on “Macaca Mulatta”
- Barton F Haynes · Duke University$291,595,855
- Peter Gordon Gillespie · Oregon Health And Science University$83,402,374
- Richard A Gibbs · Baylor College Of Medicine$82,928,769
- Dan H. Barouch · Fred Hutchinson Cancer Center$67,567,747
- David I Watkins · George Washington University$57,087,952
- Rama Rao Amara · Emory University$54,145,017
Research focus
Macaca MulattaMolecularHiv-1InnovationLigandsMacacaDesignHelper-Inducer T-LymphocyteImmune ResponseInfectious Diseases ResearchAntibody ResponseAntigensAluminum SulfateLymph NodesAdjuvantBindingFormulationB-LymphocytesAgonistBone MarrowImmunityCellsClinicNanoparticle
Grant awards (8)
Novel nanoparticulate adjuvants to enhance HIV-1 Env specific mucosal antibody responses$882,847
R01 · FY2023 · AI · contact PI
Novel nanoparticulate adjuvants to enhance HIV-1 Env specific mucosal antibody responses$883,101
R01 · FY2022 · AI · contact PI
Novel nanoparticulate adjuvants to enhance HIV-1 Env specific mucosal antibody responses$1,468,408
R01 · FY2021 · AI · contact PI
Novel nanoparticulate adjuvants to enhance HIV-1 Env specific mucosal antibody responses$895,998
R01 · FY2020 · AI · contact PI
Novel nanoparticulate adjuvants to enhance HIV-1 Env specific mucosal antibody responses$904,894
R01 · FY2019 · AI · contact PI
Modulating durability of HIV-1 env specific humoral immunity with a novel TLR7/8 targeted formulation$346,266
K01 · FY2018 · OD · contact PI
Modulating durability of HIV-1 env specific humoral immunity with a novel TLR7/8 targeted formulation$348,092
K01 · FY2017 · OD · contact PI
Modulating durability of HIV-1 env specific humoral immunity with a novel TLR7/8 targeted formulation$349,995
K01 · FY2016 · OD · contact PI